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Abstract
Background: The Gene Ontology Project provides structured controlled vocabularies for molecular
biology that can be used for the functional annotation of genes and gene products. In a collaboration
between the Gene Ontology (GO) Consortium and the muscle biology community, we have made large-
scale additions to the GO biological process and cellular component ontologies. The main focus of this
ontology development work concerns skeletal muscle, with specific consideration given to the processes
of muscle contraction, plasticity, development, and regeneration, and to the sarcomere and membrane-
delimited compartments. Our aims were to update the existing structure to reflect current knowledge,
and to resolve, in an accommodating manner, the ambiguity in the language used by the community.
Results: The updated muscle terminologies have been incorporated into the GO. There are now 159 new
terms covering critical research areas, and 57 existing terms have been improved and reorganized to
follow their usage in muscle literature.
Conclusion: The revised GO structure should improve the interpretation of data from high-throughput
(e.g. microarray and proteomic) experiments in the area of muscle science and muscle disease. We actively
encourage community feedback on, and gene product annotation with these new terms. Please visit the
Muscle Community Annotation Wiki http://wiki.geneontology.org/index.php/Muscle_Biology.
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Technical innovations in recent years have enabled the
production of vast amounts of scientific research data,
using a variety of methods, and covering many different
species. These innovations provide the opportunity for
evaluation of large datasets to generate and/or support
novel hypotheses. In dealing with this wealth of data, sci-
entists are held back by differences in technical language
among research communities, compounded by the
absence of computable information on the relationships
between biological processes.
An example of linguistic ambiguity within the muscle
biology community is seen in the use of the word 'plastic-
ity'. This word could mean the quality of adaptability, but
is often used to indicate the process of adaptation. In
addition to complicating the work of research scientists,
such ambiguity also presents real difficulties for those
who wish to write data mining software. Such software
attempts to automatically handle information about the
relationships between biological processes and between
gene products. There is a particular need for good data
mining software in high-throughput work, which is a
prominent part of current muscle biology research. The
aim of the Gene Ontology (GO) project [1,2] is to provide
a standard language for the description of gene products,
thus enabling scientists and software engineers to resolve
language problems.
To provide this standard language, the GO project is
developing ontologies and using them in annotation of
gene products. There are three non-overlapping ontology
domains, so that gene products may be categorized
according to GO terms representing the molecular func-
tions they carry out (using the Molecular Function ontol-
ogy), the cellular locations where they act (using the
Cellular Component ontology), and the biological proc-
esses in which they take part (using the Biological Process
ontology). The three ontologies are separate, but within
each ontology the GO terms are related to one another.
These relationships indicate where one category is a part
(part_of relationship) or type (is_a relationship) of
another category, or where one category regulates (regu-
lates, positively_regulates, or negatively_regulates relation-
ships) another category. For a more comprehensive
explanation see [3]. Each ontology can be used as a stand-
ard terminology to facilitate a biologically meaningful
description of the roles of genes and their products in any
organism. Gene products can be annotated to any number
of GO terms within one or more of the ontologies to cap-
ture information about their various roles within these
given domains. The Gene Ontology has for several years
included a number of terms describing muscle biology,
and the GO has already been used extensively for statisti-
cal data analysis in muscle biology studies. For example,
the GO was used in an analysis of the global transcrip-
tional changes that take place in skeletal muscle in rela-
tion to estrogen status [4], and in an expression profiling
study of the transcription factor MyoD during myogenic
differentiation [5]. However, to fully support the current
needs of the muscle research community, especially with
respect to the study of disease, a considerable expansion
of the terms relevant to muscle biology is required. We
describe here an effort to improve the structure of muscle
terms in the GO biological process and cellular compo-
nent ontologies. The work was carried out as a collabora-
tive project that brought together the GO Consortium, the
Genomic Research Group of CRIBI Biotechnology Center
at the University of Padua, and several research groups
involved in muscle biology. We sought to improve GO
terms that would specifically support muscle biology
research in areas relevant to the investigation of muscle-
related disease. By bringing together muscle and ontology
experts, the GO structure was systematically improved in
five areas: muscle contraction, plasticity, development
and regeneration; and for cell regions in the sarcomere
and membrane-delimited compartments.
Methods
Following the example of the Immunology Content Meet-
ing [6] and of other GO ontology development meetings,
the muscle-related GO Content Meeting brought together
experimental biologists and ontology developers to
define the terms relevant to this specific research field.
Content-oriented meetings facilitate large-scale changes
in specific areas of the Gene Ontology. A content meeting
is usually organized as a multi step process. The first steps
are normally done by the ontology developers, gathering
information related to the field of interest from books,
reviews and scientific papers and organizing it into an
ontological format. The ontology is finally presented to
the experts in the field during the content meeting, to be
discussed and refined. The work described in this paper
was carried out using a rather different approach. The ini-
tial steps were mainly carried out by the muscle biology
research community, while the final discussion and
refinement was carried out during a meeting with invited
ontology developers. This approach was possible because
a member of the muscle community (EF) spent six
months working in ontology development and annota-
tion at the GO editorial office and gained further experi-
ence by taking part in a previous GO content meeting. She
then rejoined her research community and led the ontol-
ogy development effort. Throughout the initial commu-
nity editing process, GO Consortium editors provided
technical assistance and advice on representation of lan-
guage by means of frequent web-based ontology editing
meetings. Following this editing phase, ontology develop-
ers from the GO Consortium were invited to meet withPage 2 of 8
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revision of the structure of the GO. This two-day meeting
was entirely devoted to live editing the GO, during which
further changes were made to its structure and content.
The community-based ontology development model was
extremely positive and productive, as it enabled the lead
ontology developer to access a wide range of domain
experts, mostly locally available, and all with cutting-edge
knowledge of the field.
At the end of October 2007, the changes were incorpo-
rated into the GO, and are now available for all GO users.
In addition to creation and improvement of GO terms,
cross-references were made with a number of other
resources. The Adult Mouse Anatomical Dictionary [7]
was used as a source of definitions and ontological struc-
turing for muscle contraction anatomical terms, and the
Cell Ontology [8] was consulted for cell type definitions.
The resulting terms were cross-referenced to these other
ontologies and, where appropriate, new definitions were
contributed to the other ontologies. For example, a new
definition of the satellite cell type was created and intro-
duced in both the Cell Type and GO ontologies, and the
resulting terms were cross-referenced. Gene Ontology
term names are given in bold in this text.
Results
The muscle research community, in collaboration with
the GO Consortium, has completed an initiative to greatly
expand the muscle biology representation in the GO bio-
logical process and cellular component ontologies. The
work focused on improving and adding terms urgently
needed for current priority areas in research.
The main focus of the work was skeletal muscle, with spe-
cific consideration given to the processes of muscle con-
traction, muscle plasticity, muscle development and
regeneration; and to the sarcomere and membrane-delim-
ited cell compartments. Our aims were to update the exist-
ing structure to reflect current knowledge, and to resolve
in an accommodating manner, the ambiguities in the lan-
guage used by the muscle community. This collaborative
effort drew on the knowledge of an extensive community
of muscle experts, and resulted in the addition of 159 new
terms and the improvement of 57 existing terms.
These different areas of muscle biology were addressed to
support specific research needs. In the following text, the
motivation for the changes and the details of each set of
changes are described.
Muscle Plasticity
There are two different possible biological meanings of
the commonly used phrase 'muscle plasticity', such that
plasticity could be either the quality of adaptability or the
process of adaptation. In ontology development it is
essential to be clear about which term represents which
process; and to ensure that the language is unambiguous,
whilst still reflecting community usage. The existing mus-
cle plasticity term was ambiguously named, risking incor-
rect use in annotation or text mining. However, as the
term was clearly defined to describe the process of adapta-
tion, we were able to resolve the problem by renaming the
term muscle adaptation (leaving muscle plasticity as a
related synonym, to help researchers find the term). This
action resolved the ambiguity, but accommodated the
common uses of the word 'plasticity' in domain literature
by retaining the word as a searchable related synonym.
There are many stimuli that bring about muscle adapta-
tion. Musculo-skeletal adaptability studies include exami-
nation of a muscle's response to joint immobilization,
spinal cord injury, electrical stimulation, chronic stretch,
exercise-induced injury, and microgravity. Adaptive
events that occur in muscle fibers and associated struc-
tures (motor neurons and capillaries) include atrophy,
hypertrophy, and hyperplasia, and these involve altera-
tions in regulatory mechanisms, contractile properties,
fiber-type compositions, and metabolic capacities. Previ-
ously these processes were not covered in the GO as the
term muscle plasticity (Figure 1A) had no more specific
child terms. During the editing work, terms covering these
important sub-processes have been included (Figure 1B).
Using these new more granular terms, biologists will be
able to annotate gene products in more detail. Prior to our
work, if a gene was thought to be involved in muscle atro-
phy, the user had only the option of annotating directly to
the general term 'muscle plasticity'. As a result of our con-
tribution, the ontology now includes child terms repre-
senting muscle atrophy, hypertrophy and hyperplasia. It
also includes generic regulation terms under each of these
processes, and under these regulation terms the actual reg-
ulatory processes are grouped. To illustrate the advantage
of creation of these new terms the muscle experts have
contributed some annotations that could previously only
be made to the general muscle plasticity term (Figure 1A)
and that can now be distributed amongst the more spe-
cific child terms for much greater reasoning power (Figure
1B). This small amount of annotation clearly shows how
much better this enhanced structure is for distinguishing
sets of gene products involved in the various processes
that contribute to the general process of muscle adapta-
tion. Though we have shown only a handful of gene prod-
ucts, it can easily be imagined how much more powerful
the system will be in automated analysis of the activity of
thousands of gene products, as is the case in a microarray
experiment. For example, once the relevant gene products
are fully annotated, it will be possible to detect by micro-Page 3 of 8
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Muscle plasticity GO nodeFigur  1
Muscle plasticity GO node. As an example, the process 'muscle plasticity' is shown before (Panel A) and after (Panel B) our 
modifications. Previously, the process of muscle plasticity had no specific child terms, therefore all annotations of the gene 
products involved in subprocesses of muscle adaptation had to be made directly to the muscle plasticity term. As part of our 
work we renamed muscle plasticity to muscle adaptation (highlighted in red) in keeping with the existing term definition, and 
added new terms for various sub-processes of muscle adaptation such as muscle atrophy, hypertrophy and hyperplasia. As a 
result of this work the gene products previously annotated directly to muscle plasticity can now be annotated to the more spe-
cific process terms giving far better reasoning power for analysis of high-throughput experiments. GO terms are in blue ovals, 
and annotated gene products are in green rectangles. Black lines marked 'is_a' indicate the is_a relationship. Black lines marked 
'regulates' indicate the regulates relationship. Red lines indicate annotation of a gene product to a GO process term. Annota-
tion of a gene product to a GO process term indicates that the gene product participates in the process represented by the 
GO term.
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of genes involved in muscle hypertrophy, whilst barely
affecting the regulation of genes involved in muscle atro-
phy.
This new set of terms should assist in the annotation of
gene products involved in the control of muscle fiber-type
diversity, providing potential new targets for the treat-
ment and prevention of different disorders ranging from
metabolic to neuromuscular diseases, for example Type 2
diabetes and muscular dystrophy [9]. We have explained
this example of muscle plasticity very fully to illustrate the
motivation behind our ontology development work. The
work carried out on other areas of the ontology will bring
similar benefits with regard to other critical areas of
research, and we describe these pieces of work somewhat
more briefly below with reference to the areas of research
that they are intended to support.
Muscle Contraction
The definition of the term muscle contraction, which pre-
viously existed in the GO, has been considerably
improved and all of its descendants have been reorgan-
ized. The new structure represents several forms of muscle
contraction and their relationships with the various types
of muscle. To reflect this, there is also a greatly expanded
set of terms describing the different contractile capacity of
muscle. Striated muscle contracts and relaxes in short,
intense bursts, whereas smooth muscle sustains longer or
even near-permanent contractions. This difference was
captured by the creation of is_a children, phasic smooth
muscle contraction and tonic smooth muscle contrac-
tion, under the parent term smooth muscle contraction.
Since the process of smooth muscle contraction varies
with the anatomical location of muscles, terms such as
vascular muscle contraction and gastro-intestinal mus-
cle contraction were also created.
Muscle contraction is actively regulated by a series of
events, for which appropriate regulation terms have been
added. These include several processes such as cross-
bridge formation, cross-bridge cycling, and filament slid-
ing, which are necessary for force generation during mus-
cle contraction. Multiple molecular components, such as
sarcoplasmic proteins, have a role in regulating the mus-
cle contraction. For instance mutations in several Z-disc
proteins in the sarcomere, that are important for the cross-
linking of thin filaments and transmission of force gener-
ated by the myofilaments, have been shown to cause car-
diomyopathies and/or muscular dystrophies [10]. To
accommodate this, a definition of the sarcomeric Z-disc
has been added to the component ontology and extended
to include recently discovered novel attributes associated
with this structure, such as mechanosensation and mech-
anotransduction, thereby allowing users to view the Z-disc
not so much as a static, but now as a flexible structure with
important implications for signal transduction as well
[11].
Calcium signaling
The previously described process of muscle plasticity is
closely linked with, and highly dependent on, calcium
metabolism and transport, as muscles use calcium ions as
their main regulatory and signaling molecule. Therefore,
calcium ion-dependent processes control the properties of
the mechanisms of contraction and relaxation in different
types of muscle fibers [12]. The sarcoplasmic reticulum
(SR) is a sub-compartment of the endoplasmic reticulum
(ER) and is molecularly specialized for calcium release,
uptake, and storage and for the contraction-relaxation
cycle in skeletal muscle fibers [13]. Recognizing the
importance of this, we focused part of our work on
improving the existing terms describing sarcoplasmic
reticulum and its role in regulating the calcium ion-
dependent processes. Terms such regulation of skeletal
muscle contraction by calcium ion signaling and regu-
lation of skeletal muscle contraction via modulation of
calcium ion sensitivity of myofibril were added as
part_of children of muscle contraction. In addition, the
sarcoplasmic reticulum compartment and its components
are covered by an expanded hierarchy of terms. Whilst the
term sarcoplasmic reticulum pre-existed in the GO (Fig-
ure 2A) we have been able to add many new child terms
(Figure 2B). This allows the gene products whose loca-
tions of action could previously only be categorized
loosely using the single sarcoplasmic reticulum term
(Figure 2A) to be categorized in far more detail (Figure
2B). We give this example in detail with annotations to
indicate how the additions to the cellular component
ontology provide similar benefits to those in the biologi-
cal processes ontology, previously illustrated by use of the
muscle plasticity example. The new child terms in this
case include longitudinal sarcoplasmic reticulum, ter-
minal cisterna, terminal cisterna lumen, free sarcoplas-
mic reticulum membrane, and junctional sarcoplasmic
reticulum membrane. These new GO terms will aid our
understanding of normal muscle processes and muscle
pathological conditions such as dystrophinopathies,
Brody's disease, and malignant hyperthermia. These have
been shown to be due to alterations in calcium ion-
dependent ion channel activities [12].
Muscle Types
Muscles can be divided into striated and smooth types.
Smooth muscle or 'involuntary muscle' is found within
structures such as the oesophagus, stomach, intestines,
bronchi, uterus, and blood vessels. Unlike skeletal mus-
cle, smooth muscle is not under conscious control. Car-
diac and skeletal muscles are striated in that they containPage 5 of 8
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Sarcoplasmic reticulum GO nodeFigure 2
Sarcoplasmic reticulum GO node. As an example, the cellular component 'sarcoplasmic reticulum' is shown before (Panel 
A) and after (Panel B) the modifications described in this paper. Previously, the term sarcoplasmic reticulum had no specific 
child terms, therefore all annotations of the gene products known to act in specific regions or sub-types of the sarcoplasmic 
reticulum had to be made directly to the parent term. As a part of our work we added new terms to describe various regions 
and sub-types. As a result, the gene products previously annotated directly to sarcoplasmic reticulum can now be annotated to 
the more specific child terms giving far better reasoning power for analysis of high-throughput experiments. Black lines marked 
'is_a' indicate the is_a relationship. Black lines marked 'part_of' indicate the 'part_of' relationship. Red lines indicate annotation 
of a gene product to a GO cellular component term. Annotation of a gene product to a GO cellular component term indicates 
that the gene product acts in the cellular location represented by the GO term.
BMC Medical Genomics 2009, 2:6 http://www.biomedcentral.com/1755-8794/2/6sarcomeres and are packed into highly regular arrange-
ments of bundles.
Skeletal muscles are further divided into two subtypes,
slow-twitch and fast-twitch muscle, depending on their
contractile capacity. The biology of these two muscle types
is key in current research, so we worked to represent it cor-
rectly as part of the biological process ontology. Improve-
ments were made to the representation of these areas, to
ensure that the usage of the words 'skeletal' and 'striated'
was representative of that in the community. Importantly,
these terms were also cross-checked by a cardiovascular
physiology community group, whose ontology develop-
ment effort took place at the same time, and which also
touched on voluntary/involuntary muscle processes
(David Hill, personal communication).
Muscle Development and Regeneration
Myofibers, the functional unit of skeletal muscle, are long
cylindrical multinucleated cells that vary in their morpho-
logical, biochemical, and physiological properties. They
are derived from myoblasts: cells committed to the skele-
tal muscle lineage. Upon fusion, myoblasts form myo-
tubes, which are further remodeled into myofibers [14].
The skeletal muscle development subtree has been
enhanced during our work with a new hierarchy of terms
describing myoblast, myotube, and myofiber develop-
ment, and the mechanisms of their regulation. To accom-
modate recent data, a distinction was introduced between
head and trunk muscle development [15].
Many terms have been added to cover the process of cell
regeneration and its regulation in skeletal muscle tissue.
These include terms such as satellite cell activation
involved in skeletal muscle regeneration and satellite
cell compartment self renewal involved in skeletal mus-
cle regeneration. Satellite cell processes are considered
particularly important, since their activation is involved in
muscle regeneration. Satellite cell proliferation, differenti-
ation, and self-renewal are essential for proper myofiber
turnover; an ongoing process that maintains proper mus-
cle tissue viability [16]. Moreover, in adult skeletal mus-
cle, the self-renewing capacity of satellite cells contributes
to muscle growth and adaptation [17]. Skeletal muscle is
capable of complete regeneration due to the presence of
stem cells that reside in skeletal muscle and non-muscle
stem cell populations. However, in severe myopathic dis-
eases such as Duchenne Muscular Dystrophy, this regen-
erative capacity is exhausted [18]. We have attempted to
support research into these areas by addition of the rele-
vant terms.
Conclusion
We have described an ontology development effort that
provides a valuable resource for functional annotation of
gene products related to muscle biology. New terms sup-
porting critical research areas are now available, and exist-
ing terms have been improved and reorganized to reflect
their usage in muscle literature. There are a number of
important advantages to a research community in having
their field accurately represented in the GO. Our revised
ontology structure should facilitate the interpretation of
high-throughput experiments (e.g. gene expression micro-
arrays) in the areas of muscle science and muscle disease.
Such studies yield a very large number of data points, so
that investigation of how genes specifically contribute to
a disease phenotype is challenging [19]. However the use
of GO ontologies and annotations in statistical analysis
should greatly simplify this [20].
Obviously, a critical component of such analysis is the
comprehensive annotation of relevant gene products. To
enable community annotation, we have provided a Mus-
cle Biology Community Annotation Wiki http://
wiki.geneontology.org/index.php/Muscle_Biology. The
wiki contains editable annotation pages for 172 genes
associated with muscle development and function.
Users can review existing Gene Ontology annotations for
any gene of interest, and add information about any
aspect of the biology of a gene from any species. They can
also contribute annotations of gene products involved in
muscle biology to all GO terms, thereby supporting the
next step in research into these critical areas of muscle
biology.
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